The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Human Prothrombin Complex Market Research Report 2024
Synopsis
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
The global Human Prothrombin Complex market was valued at US$ 1577 million in 2023 and is anticipated to reach US$ 3473.8 million by 2030, witnessing a CAGR of 11.8% during the forecast period 2024-2030.
Global Human Prothrombin Complex key players include Octapharma, Shire, CSL, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 45%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.
In terms of product, 500 IU/Vial is the largest segment, with a share over 50%. And in terms of application, the largest application is Hemophilia B, followed by Vitamin K Deficiency, etc.
This report aims to provide a comprehensive presentation of the global market for Human Prothrombin Complex, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Prothrombin Complex.
Report Scope
The Human Prothrombin Complex market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Prothrombin Complex market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Prothrombin Complex manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Takeda
CSL
Grifols
Octapharma
Hualan Biological
Meheco Xinxing Pharma
Segment by Type
500 IU/Vial
600 IU/Vial
1000 IU/Vial
Others
Segment by Application
Hemophilia B
Vitamin K Deficiency
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human Prothrombin Complex manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human Prothrombin Complex in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
The global Human Prothrombin Complex market was valued at US$ 1577 million in 2023 and is anticipated to reach US$ 3473.8 million by 2030, witnessing a CAGR of 11.8% during the forecast period 2024-2030.
Global Human Prothrombin Complex key players include Octapharma, Shire, CSL, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 45%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.
In terms of product, 500 IU/Vial is the largest segment, with a share over 50%. And in terms of application, the largest application is Hemophilia B, followed by Vitamin K Deficiency, etc.
This report aims to provide a comprehensive presentation of the global market for Human Prothrombin Complex, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Prothrombin Complex.
Report Scope
The Human Prothrombin Complex market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Prothrombin Complex market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Prothrombin Complex manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Takeda
CSL
Grifols
Octapharma
Hualan Biological
Meheco Xinxing Pharma
Segment by Type
500 IU/Vial
600 IU/Vial
1000 IU/Vial
Others
Segment by Application
Hemophilia B
Vitamin K Deficiency
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human Prothrombin Complex manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human Prothrombin Complex in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Human Prothrombin Complex Market Overview
1.1 Product Overview and Scope of Human Prothrombin Complex
1.2 Human Prothrombin Complex Segment by Type
1.2.1 Global Human Prothrombin Complex Market Value Comparison by Type (2024-2030)
1.2.2 500 IU/Vial
1.2.3 600 IU/Vial
1.2.4 1000 IU/Vial
1.2.5 Others
1.3 Human Prothrombin Complex Segment by Application
1.3.1 Global Human Prothrombin Complex Market Value by Application: (2024-2030)
1.3.2 Hemophilia B
1.3.3 Vitamin K Deficiency
1.3.4 Others
1.4 Global Human Prothrombin Complex Market Size Estimates and Forecasts
1.4.1 Global Human Prothrombin Complex Revenue 2019-2030
1.4.2 Global Human Prothrombin Complex Sales 2019-2030
1.4.3 Global Human Prothrombin Complex Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Human Prothrombin Complex Market Competition by Manufacturers
2.1 Global Human Prothrombin Complex Sales Market Share by Manufacturers (2019-2024)
2.2 Global Human Prothrombin Complex Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Human Prothrombin Complex Average Price by Manufacturers (2019-2024)
2.4 Global Human Prothrombin Complex Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Human Prothrombin Complex, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Prothrombin Complex, Product Type & Application
2.7 Human Prothrombin Complex Market Competitive Situation and Trends
2.7.1 Human Prothrombin Complex Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Human Prothrombin Complex Players Market Share by Revenue
2.7.3 Global Human Prothrombin Complex Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Human Prothrombin Complex Retrospective Market Scenario by Region
3.1 Global Human Prothrombin Complex Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Human Prothrombin Complex Global Human Prothrombin Complex Sales by Region: 2019-2030
3.2.1 Global Human Prothrombin Complex Sales by Region: 2019-2024
3.2.2 Global Human Prothrombin Complex Sales by Region: 2025-2030
3.3 Global Human Prothrombin Complex Global Human Prothrombin Complex Revenue by Region: 2019-2030
3.3.1 Global Human Prothrombin Complex Revenue by Region: 2019-2024
3.3.2 Global Human Prothrombin Complex Revenue by Region: 2025-2030
3.4 North America Human Prothrombin Complex Market Facts & Figures by Country
3.4.1 North America Human Prothrombin Complex Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Human Prothrombin Complex Sales by Country (2019-2030)
3.4.3 North America Human Prothrombin Complex Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Human Prothrombin Complex Market Facts & Figures by Country
3.5.1 Europe Human Prothrombin Complex Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Human Prothrombin Complex Sales by Country (2019-2030)
3.5.3 Europe Human Prothrombin Complex Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Prothrombin Complex Market Facts & Figures by Country
3.6.1 Asia Pacific Human Prothrombin Complex Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Human Prothrombin Complex Sales by Country (2019-2030)
3.6.3 Asia Pacific Human Prothrombin Complex Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Human Prothrombin Complex Market Facts & Figures by Country
3.7.1 Latin America Human Prothrombin Complex Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Human Prothrombin Complex Sales by Country (2019-2030)
3.7.3 Latin America Human Prothrombin Complex Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Prothrombin Complex Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Prothrombin Complex Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Human Prothrombin Complex Sales by Country (2019-2030)
3.8.3 Middle East and Africa Human Prothrombin Complex Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Human Prothrombin Complex Sales by Type (2019-2030)
4.1.1 Global Human Prothrombin Complex Sales by Type (2019-2024)
4.1.2 Global Human Prothrombin Complex Sales by Type (2025-2030)
4.1.3 Global Human Prothrombin Complex Sales Market Share by Type (2019-2030)
4.2 Global Human Prothrombin Complex Revenue by Type (2019-2030)
4.2.1 Global Human Prothrombin Complex Revenue by Type (2019-2024)
4.2.2 Global Human Prothrombin Complex Revenue by Type (2025-2030)
4.2.3 Global Human Prothrombin Complex Revenue Market Share by Type (2019-2030)
4.3 Global Human Prothrombin Complex Price by Type (2019-2030)
5 Segment by Application
5.1 Global Human Prothrombin Complex Sales by Application (2019-2030)
5.1.1 Global Human Prothrombin Complex Sales by Application (2019-2024)
5.1.2 Global Human Prothrombin Complex Sales by Application (2025-2030)
5.1.3 Global Human Prothrombin Complex Sales Market Share by Application (2019-2030)
5.2 Global Human Prothrombin Complex Revenue by Application (2019-2030)
5.2.1 Global Human Prothrombin Complex Revenue by Application (2019-2024)
5.2.2 Global Human Prothrombin Complex Revenue by Application (2025-2030)
5.2.3 Global Human Prothrombin Complex Revenue Market Share by Application (2019-2030)
5.3 Global Human Prothrombin Complex Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Takeda
6.1.1 Takeda Corporation Information
6.1.2 Takeda Description and Business Overview
6.1.3 Takeda Human Prothrombin Complex Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Takeda Human Prothrombin Complex Product Portfolio
6.1.5 Takeda Recent Developments/Updates
6.2 CSL
6.2.1 CSL Corporation Information
6.2.2 CSL Description and Business Overview
6.2.3 CSL Human Prothrombin Complex Sales, Revenue and Gross Margin (2019-2024)
6.2.4 CSL Human Prothrombin Complex Product Portfolio
6.2.5 CSL Recent Developments/Updates
6.3 Grifols
6.3.1 Grifols Corporation Information
6.3.2 Grifols Description and Business Overview
6.3.3 Grifols Human Prothrombin Complex Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Grifols Human Prothrombin Complex Product Portfolio
6.3.5 Grifols Recent Developments/Updates
6.4 Octapharma
6.4.1 Octapharma Corporation Information
6.4.2 Octapharma Description and Business Overview
6.4.3 Octapharma Human Prothrombin Complex Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Octapharma Human Prothrombin Complex Product Portfolio
6.4.5 Octapharma Recent Developments/Updates
6.5 Hualan Biological
6.5.1 Hualan Biological Corporation Information
6.5.2 Hualan Biological Description and Business Overview
6.5.3 Hualan Biological Human Prothrombin Complex Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Hualan Biological Human Prothrombin Complex Product Portfolio
6.5.5 Hualan Biological Recent Developments/Updates
6.6 Meheco Xinxing Pharma
6.6.1 Meheco Xinxing Pharma Corporation Information
6.6.2 Meheco Xinxing Pharma Description and Business Overview
6.6.3 Meheco Xinxing Pharma Human Prothrombin Complex Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Meheco Xinxing Pharma Human Prothrombin Complex Product Portfolio
6.6.5 Meheco Xinxing Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Prothrombin Complex Industry Chain Analysis
7.2 Human Prothrombin Complex Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Prothrombin Complex Production Mode & Process
7.4 Human Prothrombin Complex Sales and Marketing
7.4.1 Human Prothrombin Complex Sales Channels
7.4.2 Human Prothrombin Complex Distributors
7.5 Human Prothrombin Complex Customers
8 Human Prothrombin Complex Market Dynamics
8.1 Human Prothrombin Complex Industry Trends
8.2 Human Prothrombin Complex Market Drivers
8.3 Human Prothrombin Complex Market Challenges
8.4 Human Prothrombin Complex Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
